Ostbring 2018.

Methods	RCT
Participants	Inclusion: 18 years or older, admitted for angiography, verified coronary artery disease, planned for follow‐up at the outpatient clinic, Swedish speaking Exclusion: cognitive impairment or any other condition making interview or phone calls impossible, non‐participation in standard follow‐up, prior participation in this study (pilot)
Interventions	Intervention: medication review and motivational interviewing (MI) for patients with coronary heart disease (CHD). Clinical pharmacists competent in MI and cardiology will conduct medication interviews and medication reviews at the outpatient clinic. Intervention will continue during 9 months, with interviews and reviews as needed. Follow‐up of results will take place 16 months after inclusion (corresponding to 4 months after end of intervention) Control: usual care
Outcomes	Cholesterol levels, percentage of patients adherent to individual medications (cholesterol, ACE inhibitors, acetylsalicylic acid, PSY‐12 antagonist, and beta‐blocker), blood pressure, quality of life, hospital re‐admissions, emergency department visits
Notes	NCT02102503 Protocol published 2018. Extension of earlier pilot study (Ostbring 2014), which was excluded due to short follow‐up Unclear whether overall adherence measure will be provided. Age and number of medications unavailable (but pilot study met eligibility) Publication anticipated 2019